DESKTOP III Trial -ASCO 2017 Abstract

Results of DESKTOP III ( Progression Free Survival) have been published recently in ASCO Abstracts

The median Progression free survival in patients undergoing secondary cytoreduction for relapsed ovarian cancer (with 6 months plus platinum free interval, positive AGO score ie., ECOG 0,<500 mL Ascites, complete resection at first surgery) was 19.6 months versus 14 months without surgery.

The abstract can be accessed here

http://abstracts.asco.org/199/AbstView_199_187518.html

 

Advertisements